FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Rugby Laboratories Recalls Diocto Liquid and Syrup

FDA says Rugby Laboratories is recalling all lots of Diocto Liquid and Dicoto Syrup manufactured by PharmaTech due to possible contamination.

Human Drugs

FDA Panel Thumbs Down on Janssen Arthritis Drug

FDAs Arthritis Advisory Committee votes 12 to 1 against recommending approval of a Janssen Biotech BLA for Plivensia (sirukumab), citing safety concer...

Human Drugs

Jenkins Delayed Retirement to Protect Drug Reviews from Woodcock

A new email released under a lawsuit against FDA shows that former Office of New Drugs director John Jenkins delayed his planned retirement last year ...

Human Drugs

Senate Passes User Fee Reauthorization Bill

The Senate passes an FDA user fee reauthorization bill to fund agency product reviews and related activities for the next five years.

Human Drugs

Randomized Clinical Trial Alternatives Explored

Former CDC director Thomas Frieden says researchers need to be open to using new methods that may work better than randomized clinical trials in speci...

Human Drugs

2 FDA REMS Updates Announced

FDA announces updates to the REMS@FDA Web site.

Human Drugs

New DoJ Opioid Fraud and Abuse Detection Unit

Attorney General Jeff Sessions announces formation of a pilot program to use data to help combat the nations opioid crisis.

Federal Register

FDA Webinar on OTC Monograph User Fees

Federal Register notice: FDA announces an 8/23 Webinar to provide stakeholders with a status update on the process of FDA and industry discussions on ...

Medical Devices

Public Meeting on 3D Printing of Anatomic Models

CDRH and the Radiological Society of North America 3D Printing Special Interest Group announce an 8/31 joint meeting on the clinical use of 3D printed...

Human Drugs

Coherus Wants Delay in Neulasta Case Discovery

Patterson Belknap attorneys say that Coherus BioSciences is asking a federal court to delay discovery in a Neulasta patent dispute with Amgen until th...